疫苗护照盖章?法国、德国和瑞典公众对为已接种疫苗者放宽COVID-19相关限制的支持度
该研究基于2021年4月法国(N=1,752)、德国(N=1,759)和瑞典(N=1,754)的代表性配额样本,分析公众对仅为已接种疫苗者放宽限制的支持度及相关因素。结果显示,法国和德国略占多数的公众支持该政策,而瑞典不支持;疫苗犹豫是反对该政策的强预测因素,已接种疫苗(法、德)和风险寻求倾向较高者更支持放宽限制。
要点
- 法国和德国略占多数的公众支持为已接种疫苗者放宽限制,瑞典则不支持。
- 疫苗犹豫是反对为已接种疫苗者放宽限制的强预测因素。
- 在法国和德国,已接种疫苗者及风险寻求倾向较高者更支持放宽限制。
核心结论
- 法国和德国略占多数的公众支持为已接种疫苗者放宽COVID-19限制,瑞典不支持;疫苗犹豫是反对该政策的强预测因素。
研究设计与样本
- 采用法国(N=1,752)、德国(N=1,759)和瑞典(N=1,754)的代表性配额样本进行分析。
主要发现
- 法国和德国略占多数的公众支持为已接种疫苗者放宽限制,瑞典不支持。
- 疫苗犹豫是反对为已接种疫苗者放宽限制的强预测因素。
- 在法国和德国,已接种疫苗者及风险寻求倾向较高者更支持放宽限制。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
During theCOVID-19pandemic,manycountries implementedrestrictionsto limit the spread of the SARS-CoV-2 virus (e.g. travel restrictions and lockdowns).One path to loosening restrictions is to do so selectively only for vaccinated individuals (e.g. by implementing vaccine passports domestically or as a prerequisite for international travel).Setting different rules based on people's vaccination statusis howevera contentious issue among health policy experts, government officials, and the public. Our analysis focuses on the levels and correlates of public support for the lifting of restrictions for the vaccinatedin April 2021, i.e. at a time when restrictions were in place and aselective lifting of these restrictions just for the vaccinatedwas debated in Europe.We use representative quota samples of the populations of France (N = 1,752), Germany (N = 1,759), and Sweden (N = 1,754). We find that a slight plurality support lifting restrictions for the vaccinated in France and Germany but not in Sweden. Vaccine hesitancy emerges as strong predictor of opposition to such a policy. Additionally, individuals who are already vaccinated (in France and Germany) and who are higher in risk-seeking express more support for the lifting of restrictions for the vaccinated. We discuss implications for the debate on vaccine passports.
引用
- Stoeckel F, Stöckli S, Phillips J, et al. Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden. Vaccine. 2022. PMID: 36008231. doi:10.1016/j.vaccine.2022.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。